世界のてんかん市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Epilepsy Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2234 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、てんかんのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（部分発作/焦点発作、全身性発作、ミオクローヌスミス、陰性ミオクローヌス、まぶたミオクローヌス、痙笑、その他）、用途別市場規模（病院、神経内科センター、在宅ケア施設、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・てんかんの市場動向 ・企業の競争状況、市場シェア ・てんかんの種類別市場規模（部分発作/焦点発作、全身性発作、ミオクローヌスミス、陰性ミオクローヌス、まぶたミオクローヌス、痙笑、その他） ・てんかんの用途別市場規模（病院、神経内科センター、在宅ケア施設、外来手術センター、その他） ・てんかんの北米市場規模2016-2027（アメリカ、カナダ） ・てんかんのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・てんかんのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・てんかんの中南米市場規模2016-2027（メキシコ、ブラジル） ・てんかんの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（LivaNova、Johnson & Johnson Services、Eisai、GlaxoSmithKline PLC、Pfizer、UCB SA、Medtronic PLC (Ireland)、NeuroPace、Novartis AG、GW Pharmaceuticals、Abbott Laboratories、Sanofi、Sunovion Pharmaceuticals、Bausch Health、Takeda） ・結論

Market Analysis and Insights: Global Epilepsy Market
The global Epilepsy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Epilepsy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Epilepsy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Epilepsy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Epilepsy market.

Global Epilepsy Scope and Market Size
Epilepsy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Epilepsy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Partial/focal Seizure
Generalized Seizure
Myoclonus Misses
Negative Myoclonus
Eyelid Myoclonus
Laughter
Others

Segment by Application
Hospitals
Neurology Centers
Home Care Settings
Ambulatory Surgical Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
LivaNova
Johnson & Johnson Services
Eisai
GlaxoSmithKline PLC
Pfizer
UCB SA
Medtronic PLC (Ireland)
NeuroPace
Novartis AG
GW Pharmaceuticals
Abbott Laboratories
Sanofi
Sunovion Pharmaceuticals

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Epilepsy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Partial/focal Seizure
1.2.3 Generalized Seizure
1.2.4 Myoclonus Misses
1.2.5 Negative Myoclonus
1.2.6 Eyelid Myoclonus
1.2.7 Laughter
1.2.8 Others
1.3 Market by Application
1.3.1 Global Epilepsy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Neurology Centers
1.3.4 Home Care Settings
1.3.5 Ambulatory Surgical Centers
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Epilepsy Market Perspective (2016-2027)
2.2 Epilepsy Growth Trends by Regions
2.2.1 Epilepsy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Epilepsy Historic Market Share by Regions (2016-2021)
2.2.3 Epilepsy Forecasted Market Size by Regions (2022-2027)
2.3 Epilepsy Industry Dynamic
2.3.1 Epilepsy Market Trends
2.3.2 Epilepsy Market Drivers
2.3.3 Epilepsy Market Challenges
2.3.4 Epilepsy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Epilepsy Players by Revenue
3.1.1 Global Top Epilepsy Players by Revenue (2016-2021)
3.1.2 Global Epilepsy Revenue Market Share by Players (2016-2021)
3.2 Global Epilepsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Epilepsy Revenue
3.4 Global Epilepsy Market Concentration Ratio
3.4.1 Global Epilepsy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Epilepsy Revenue in 2020
3.5 Epilepsy Key Players Head office and Area Served
3.6 Key Players Epilepsy Product Solution and Service
3.7 Date of Enter into Epilepsy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Epilepsy Breakdown Data by Type
4.1 Global Epilepsy Historic Market Size by Type (2016-2021)
4.2 Global Epilepsy Forecasted Market Size by Type (2022-2027)

5 Epilepsy Breakdown Data by Application
5.1 Global Epilepsy Historic Market Size by Application (2016-2021)
5.2 Global Epilepsy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Epilepsy Market Size (2016-2027)
6.2 North America Epilepsy Market Size by Type
6.2.1 North America Epilepsy Market Size by Type (2016-2021)
6.2.2 North America Epilepsy Market Size by Type (2022-2027)
6.2.3 North America Epilepsy Market Size by Type (2016-2027)
6.3 North America Epilepsy Market Size by Application
6.3.1 North America Epilepsy Market Size by Application (2016-2021)
6.3.2 North America Epilepsy Market Size by Application (2022-2027)
6.3.3 North America Epilepsy Market Size by Application (2016-2027)
6.4 North America Epilepsy Market Size by Country
6.4.1 North America Epilepsy Market Size by Country (2016-2021)
6.4.2 North America Epilepsy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Epilepsy Market Size (2016-2027)
7.2 Europe Epilepsy Market Size by Type
7.2.1 Europe Epilepsy Market Size by Type (2016-2021)
7.2.2 Europe Epilepsy Market Size by Type (2022-2027)
7.2.3 Europe Epilepsy Market Size by Type (2016-2027)
7.3 Europe Epilepsy Market Size by Application
7.3.1 Europe Epilepsy Market Size by Application (2016-2021)
7.3.2 Europe Epilepsy Market Size by Application (2022-2027)
7.3.3 Europe Epilepsy Market Size by Application (2016-2027)
7.4 Europe Epilepsy Market Size by Country
7.4.1 Europe Epilepsy Market Size by Country (2016-2021)
7.4.2 Europe Epilepsy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Epilepsy Market Size (2016-2027)
8.2 Asia-Pacific Epilepsy Market Size by Type
8.2.1 Asia-Pacific Epilepsy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Epilepsy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Epilepsy Market Size by Type (2016-2027)
8.3 Asia-Pacific Epilepsy Market Size by Application
8.3.1 Asia-Pacific Epilepsy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Epilepsy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Epilepsy Market Size by Application (2016-2027)
8.4 Asia-Pacific Epilepsy Market Size by Region
8.4.1 Asia-Pacific Epilepsy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Epilepsy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Epilepsy Market Size (2016-2027)
9.2 Latin America Epilepsy Market Size by Type
9.2.1 Latin America Epilepsy Market Size by Type (2016-2021)
9.2.2 Latin America Epilepsy Market Size by Type (2022-2027)
9.2.3 Latin America Epilepsy Market Size by Type (2016-2027)
9.3 Latin America Epilepsy Market Size by Application
9.3.1 Latin America Epilepsy Market Size by Application (2016-2021)
9.3.2 Latin America Epilepsy Market Size by Application (2022-2027)
9.3.3 Latin America Epilepsy Market Size by Application (2016-2027)
9.4 Latin America Epilepsy Market Size by Country
9.4.1 Latin America Epilepsy Market Size by Country (2016-2021)
9.4.2 Latin America Epilepsy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Epilepsy Market Size (2016-2027)
10.2 Middle East & Africa Epilepsy Market Size by Type
10.2.1 Middle East & Africa Epilepsy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Epilepsy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Epilepsy Market Size by Type (2016-2027)
10.3 Middle East & Africa Epilepsy Market Size by Application
10.3.1 Middle East & Africa Epilepsy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Epilepsy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Epilepsy Market Size by Application (2016-2027)
10.4 Middle East & Africa Epilepsy Market Size by Country
10.4.1 Middle East & Africa Epilepsy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Epilepsy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 LivaNova
11.1.1 LivaNova Company Details
11.1.2 LivaNova Business Overview
11.1.3 LivaNova Epilepsy Introduction
11.1.4 LivaNova Revenue in Epilepsy Business (2016-2021)
11.1.5 LivaNova Recent Development
11.2 Johnson & Johnson Services
11.2.1 Johnson & Johnson Services Company Details
11.2.2 Johnson & Johnson Services Business Overview
11.2.3 Johnson & Johnson Services Epilepsy Introduction
11.2.4 Johnson & Johnson Services Revenue in Epilepsy Business (2016-2021)
11.2.5 Johnson & Johnson Services Recent Development
11.3 Eisai
11.3.1 Eisai Company Details
11.3.2 Eisai Business Overview
11.3.3 Eisai Epilepsy Introduction
11.3.4 Eisai Revenue in Epilepsy Business (2016-2021)
11.3.5 Eisai Recent Development
11.4 GlaxoSmithKline PLC
11.4.1 GlaxoSmithKline PLC Company Details
11.4.2 GlaxoSmithKline PLC Business Overview
11.4.3 GlaxoSmithKline PLC Epilepsy Introduction
11.4.4 GlaxoSmithKline PLC Revenue in Epilepsy Business (2016-2021)
11.4.5 GlaxoSmithKline PLC Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Epilepsy Introduction
11.5.4 Pfizer Revenue in Epilepsy Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 UCB SA
11.6.1 UCB SA Company Details
11.6.2 UCB SA Business Overview
11.6.3 UCB SA Epilepsy Introduction
11.6.4 UCB SA Revenue in Epilepsy Business (2016-2021)
11.6.5 UCB SA Recent Development
11.7 Medtronic PLC (Ireland)
11.7.1 Medtronic PLC (Ireland) Company Details
11.7.2 Medtronic PLC (Ireland) Business Overview
11.7.3 Medtronic PLC (Ireland) Epilepsy Introduction
11.7.4 Medtronic PLC (Ireland) Revenue in Epilepsy Business (2016-2021)
11.7.5 Medtronic PLC (Ireland) Recent Development
11.8 NeuroPace
11.8.1 NeuroPace Company Details
11.8.2 NeuroPace Business Overview
11.8.3 NeuroPace Epilepsy Introduction
11.8.4 NeuroPace Revenue in Epilepsy Business (2016-2021)
11.8.5 NeuroPace Recent Development
11.9 Novartis AG
11.9.1 Novartis AG Company Details
11.9.2 Novartis AG Business Overview
11.9.3 Novartis AG Epilepsy Introduction
11.9.4 Novartis AG Revenue in Epilepsy Business (2016-2021)
11.9.5 Novartis AG Recent Development
11.10 GW Pharmaceuticals
11.10.1 GW Pharmaceuticals Company Details
11.10.2 GW Pharmaceuticals Business Overview
11.10.3 GW Pharmaceuticals Epilepsy Introduction
11.10.4 GW Pharmaceuticals Revenue in Epilepsy Business (2016-2021)
11.10.5 GW Pharmaceuticals Recent Development
11.11 Abbott Laboratories
11.11.1 Abbott Laboratories Company Details
11.11.2 Abbott Laboratories Business Overview
11.11.3 Abbott Laboratories Epilepsy Introduction
11.11.4 Abbott Laboratories Revenue in Epilepsy Business (2016-2021)
11.11.5 Abbott Laboratories Recent Development
11.12 Sanofi
11.12.1 Sanofi Company Details
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Epilepsy Introduction
11.12.4 Sanofi Revenue in Epilepsy Business (2016-2021)
11.12.5 Sanofi Recent Development
11.13 Sunovion Pharmaceuticals
11.13.1 Sunovion Pharmaceuticals Company Details
11.13.2 Sunovion Pharmaceuticals Business Overview
11.13.3 Sunovion Pharmaceuticals Epilepsy Introduction
11.13.4 Sunovion Pharmaceuticals Revenue in Epilepsy Business (2016-2021)
11.13.5 Sunovion Pharmaceuticals Recent Development
11.14 Bausch Health
11.14.1 Bausch Health Company Details
11.14.2 Bausch Health Business Overview
11.14.3 Bausch Health Epilepsy Introduction
11.14.4 Bausch Health Revenue in Epilepsy Business (2016-2021)
11.14.5 Bausch Health Recent Development
11.15 Takeda
11.15.1 Takeda Company Details
11.15.2 Takeda Business Overview
11.15.3 Takeda Epilepsy Introduction
11.15.4 Takeda Revenue in Epilepsy Business (2016-2021)
11.15.5 Takeda Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Epilepsy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Partial/focal Seizure
Table 3. Key Players of Generalized Seizure
Table 4. Key Players of Myoclonus Misses
Table 5. Key Players of Negative Myoclonus
Table 6. Key Players of Eyelid Myoclonus
Table 7. Key Players of Laughter
Table 8. Key Players of Others
Table 9. Global Epilepsy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Epilepsy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Epilepsy Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Epilepsy Market Share by Regions (2016-2021)
Table 13. Global Epilepsy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Epilepsy Market Share by Regions (2022-2027)
Table 15. Epilepsy Market Trends
Table 16. Epilepsy Market Drivers
Table 17. Epilepsy Market Challenges
Table 18. Epilepsy Market Restraints
Table 19. Global Epilepsy Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Epilepsy Market Share by Players (2016-2021)
Table 21. Global Top Epilepsy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epilepsy as of 2020)
Table 22. Ranking of Global Top Epilepsy Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Epilepsy Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Epilepsy Product Solution and Service
Table 26. Date of Enter into Epilepsy Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Epilepsy Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Epilepsy Revenue Market Share by Type (2016-2021)
Table 30. Global Epilepsy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Epilepsy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Epilepsy Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Epilepsy Revenue Market Share by Application (2016-2021)
Table 34. Global Epilepsy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Epilepsy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Epilepsy Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Epilepsy Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Epilepsy Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Epilepsy Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Epilepsy Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Epilepsy Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Epilepsy Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Epilepsy Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Epilepsy Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Epilepsy Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Epilepsy Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Epilepsy Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Epilepsy Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Epilepsy Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Epilepsy Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Epilepsy Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Epilepsy Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Epilepsy Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Epilepsy Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Epilepsy Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Epilepsy Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Epilepsy Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Epilepsy Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Epilepsy Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Epilepsy Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Epilepsy Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Epilepsy Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Epilepsy Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Epilepsy Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Epilepsy Market Size by Country (2022-2027) & (US$ Million)
Table 66. LivaNova Company Details
Table 67. LivaNova Business Overview
Table 68. LivaNova Epilepsy Product
Table 69. LivaNova Revenue in Epilepsy Business (2016-2021) & (US$ Million)
Table 70. LivaNova Recent Development
Table 71. Johnson & Johnson Services Company Details
Table 72. Johnson & Johnson Services Business Overview
Table 73. Johnson & Johnson Services Epilepsy Product
Table 74. Johnson & Johnson Services Revenue in Epilepsy Business (2016-2021) & (US$ Million)
Table 75. Johnson & Johnson Services Recent Development
Table 76. Eisai Company Details
Table 77. Eisai Business Overview
Table 78. Eisai Epilepsy Product
Table 79. Eisai Revenue in Epilepsy Business (2016-2021) & (US$ Million)
Table 80. Eisai Recent Development
Table 81. GlaxoSmithKline PLC Company Details
Table 82. GlaxoSmithKline PLC Business Overview
Table 83. GlaxoSmithKline PLC Epilepsy Product
Table 84. GlaxoSmithKline PLC Revenue in Epilepsy Business (2016-2021) & (US$ Million)
Table 85. GlaxoSmithKline PLC Recent Development
Table 86. Pfizer Company Details
Table 87. Pfizer Business Overview
Table 88. Pfizer Epilepsy Product
Table 89. Pfizer Revenue in Epilepsy Business (2016-2021) & (US$ Million)
Table 90. Pfizer Recent Development
Table 91. UCB SA Company Details
Table 92. UCB SA Business Overview
Table 93. UCB SA Epilepsy Product
Table 94. UCB SA Revenue in Epilepsy Business (2016-2021) & (US$ Million)
Table 95. UCB SA Recent Development
Table 96. Medtronic PLC (Ireland) Company Details
Table 97. Medtronic PLC (Ireland) Business Overview
Table 98. Medtronic PLC (Ireland) Epilepsy Product
Table 99. Medtronic PLC (Ireland) Revenue in Epilepsy Business (2016-2021) & (US$ Million)
Table 100. Medtronic PLC (Ireland) Recent Development
Table 101. NeuroPace Company Details
Table 102. NeuroPace Business Overview
Table 103. NeuroPace Revenue in Epilepsy Business (2016-2021) & (US$ Million)
Table 104. NeuroPace Recent Development
Table 105. Novartis AG Company Details
Table 106. Novartis AG Business Overview
Table 107. Novartis AG Epilepsy Product
Table 108. Novartis AG Revenue in Epilepsy Business (2016-2021) & (US$ Million)
Table 109. Novartis AG Recent Development
Table 110. GW Pharmaceuticals Company Details
Table 111. GW Pharmaceuticals Business Overview
Table 112. GW Pharmaceuticals Epilepsy Product
Table 113. GW Pharmaceuticals Revenue in Epilepsy Business (2016-2021) & (US$ Million)
Table 114. GW Pharmaceuticals Recent Development
Table 115. Abbott Laboratories Company Details
Table 116. Abbott Laboratories Business Overview
Table 117. Abbott Laboratories Epilepsy Product
Table 118. Abbott Laboratories Revenue in Epilepsy Business (2016-2021) & (US$ Million)
Table 119. Abbott Laboratories Recent Development
Table 120. Sanofi Company Details
Table 121. Sanofi Business Overview
Table 122. Sanofi Epilepsy Product
Table 123. Sanofi Revenue in Epilepsy Business (2016-2021) & (US$ Million)
Table 124. Sanofi Recent Development
Table 125. Sunovion Pharmaceuticals Company Details
Table 126. Sunovion Pharmaceuticals Business Overview
Table 127. Sunovion Pharmaceuticals Epilepsy Product
Table 128. Sunovion Pharmaceuticals Revenue in Epilepsy Business (2016-2021) & (US$ Million)
Table 129. Sunovion Pharmaceuticals Recent Development
Table 130. Bausch Health Company Details
Table 131. Bausch Health Business Overview
Table 132. Bausch Health Epilepsy Product
Table 133. Bausch Health Revenue in Epilepsy Business (2016-2021) & (US$ Million)
Table 134. Bausch Health Recent Development
Table 135. Takeda Company Details
Table 136. Takeda Business Overview
Table 137. Takeda Epilepsy Product
Table 138. Takeda Revenue in Epilepsy Business (2016-2021) & (US$ Million)
Table 139. Takeda Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Epilepsy Market Share by Type: 2020 VS 2027
Figure 2. Partial/focal Seizure Features
Figure 3. Generalized Seizure Features
Figure 4. Myoclonus Misses Features
Figure 5. Negative Myoclonus Features
Figure 6. Eyelid Myoclonus Features
Figure 7. Laughter Features
Figure 8. Others Features
Figure 9. Global Epilepsy Market Share by Application: 2020 VS 2027
Figure 10. Hospitals Case Studies
Figure 11. Neurology Centers Case Studies
Figure 12. Home Care Settings Case Studies
Figure 13. Ambulatory Surgical Centers Case Studies
Figure 14. Others Case Studies
Figure 15. Epilepsy Report Years Considered
Figure 16. Global Epilepsy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Epilepsy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Epilepsy Market Share by Regions: 2020 VS 2027
Figure 19. Global Epilepsy Market Share by Regions (2022-2027)
Figure 20. Global Epilepsy Market Share by Players in 2020
Figure 21. Global Top Epilepsy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epilepsy as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Epilepsy Revenue in 2020
Figure 23. Global Epilepsy Revenue Market Share by Type (2016-2021)
Figure 24. Global Epilepsy Revenue Market Share by Type (2022-2027)
Figure 25. North America Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Epilepsy Market Share by Type (2016-2027)
Figure 27. North America Epilepsy Market Share by Application (2016-2027)
Figure 28. North America Epilepsy Market Share by Country (2016-2027)
Figure 29. United States Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Epilepsy Market Share by Type (2016-2027)
Figure 33. Europe Epilepsy Market Share by Application (2016-2027)
Figure 34. Europe Epilepsy Market Share by Country (2016-2027)
Figure 35. Germany Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Epilepsy Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Epilepsy Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Epilepsy Market Share by Region (2016-2027)
Figure 45. China Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Epilepsy Market Share by Type (2016-2027)
Figure 53. Latin America Epilepsy Market Share by Application (2016-2027)
Figure 54. Latin America Epilepsy Market Share by Country (2016-2027)
Figure 55. Mexico Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Epilepsy Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Epilepsy Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Epilepsy Market Share by Country (2016-2027)
Figure 61. Turkey Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. LivaNova Revenue Growth Rate in Epilepsy Business (2016-2021)
Figure 65. Johnson & Johnson Services Revenue Growth Rate in Epilepsy Business (2016-2021)
Figure 66. Eisai Revenue Growth Rate in Epilepsy Business (2016-2021)
Figure 67. GlaxoSmithKline PLC Revenue Growth Rate in Epilepsy Business (2016-2021)
Figure 68. Pfizer Revenue Growth Rate in Epilepsy Business (2016-2021)
Figure 69. UCB SA Revenue Growth Rate in Epilepsy Business (2016-2021)
Figure 70. Medtronic PLC (Ireland) Revenue Growth Rate in Epilepsy Business (2016-2021)
Figure 71. NeuroPace Revenue Growth Rate in Epilepsy Business (2016-2021)
Figure 72. Novartis AG Revenue Growth Rate in Epilepsy Business (2016-2021)
Figure 73. GW Pharmaceuticals Revenue Growth Rate in Epilepsy Business (2016-2021)
Figure 74. Abbott Laboratories Revenue Growth Rate in Epilepsy Business (2016-2021)
Figure 75. Sanofi Revenue Growth Rate in Epilepsy Business (2016-2021)
Figure 76. Sunovion Pharmaceuticals Revenue Growth Rate in Epilepsy Business (2016-2021)
Figure 77. Bausch Health Revenue Growth Rate in Epilepsy Business (2016-2021)
Figure 78. Takeda Revenue Growth Rate in Epilepsy Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed

---